Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Topics Community

Article

SLC1A5 is a novel biomarker associated with ferroptosis and the tumor microenvironment: a pancancer analysis

10 Aug 2023

Abstract excerpt

Solute carrier family 1 member 5 (SLC1A5) is a member of the solute carrier (SLC) superfamily of transporters and plays an important role in tumors as a key transporter of glutamine into cells. However, the relationship between SLC1A5, which is involved in immune regulation, and immune cell infiltration in the tumor microenvironment has not been elucidated, and the relationship between SLC1A5 and ferroptosis is...

Topics

Join the communities discussing this publication.

Cancer-related molecular mechanisms research
Ferroptosis and cancer prognosis
RNA modifications and cancer

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 37566748
DOI: 10.18632/aging.204911

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 31 Aug 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

SLC1A5 is a novel biomarker associated with ferroptosis and the tumor microenvironment: a pancancer analysisPMID 37566748Read ↗

SLC1A5 enhances malignant phenotypes through modulating ferroptosis status and immune microenvironment in gliomaSemantic proximity Read ↗

SLC1A5 Enhances Malignant Phenotypes Through Modulating Ferroptosis Status and Immune Microenvironment in GliomaSemantic proximity Read ↗

Identification of SLC1A5 as a Novel Candidate Oncogene for Glioma and Its Involvement in the LGG Immune MicroenvironmentSemantic proximity Read ↗

A Pan-Cancer Analysis of SLC12A5 Reveals Its Correlations with Tumor Immunity.Semantic proximity Read ↗

A pan-cancer analysis of SLC1A5 in human cancersSemantic proximity Read ↗

A comprehensive analysis of SLC25A1 expression and its oncogenic role in pan-cancerSemantic proximity Read ↗

SLC12A9 is an immunological and prognostic biomarker for glioma.Semantic proximity Read ↗

SLC7A5 is a lung adenocarcinoma-specific prognostic biomarker and participates in forming immunosuppressive tumor microenvironmentSemantic proximity Read ↗

Comprehensive Analysis and Validation of Solute Carrier Family 25 (SLC25) and Its Correlation with Immune Infiltration in Pan‐CancerSemantic proximity Read ↗

A potassium‐chloride co‐transporter with altered genome architecture functions as a suppressor in gliomaSemantic proximity Read ↗

Comprehensive analysis of 33 human cancers reveals clinical implications and immunotherapeutic value of the solute carrier family 35 member A2.Semantic proximity Read ↗

SLC1A5 Prefers to Play as an Accomplice Rather Than an Opponent in Pancreatic AdenocarcinomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.